Mono Pharmacare Limited — Board Meeting, 14-11-2024: Outcome of Board Meeting

The Board of Directors of Mono Pharmacare Limited has convened and approved the standalone and consolidated unaudited financial results for the half-year ending September 30, 2024. Key highlights include total revenue of ₹443.83 crore and a profit of ₹2.30 crore for the standalone results. Additionally, the Board has reconstituted the Audit and Stakeholders Relationship Committees. This meeting signifies strategic advancement amidst ongoing business operations, aligning with the company's growth objectives.